IGF1R and desmoplastic small round cell tumor: Of clinical significance, IGF2 is one of the ligands of the IGF-1R pathway that leads to cell proliferation and survival and anecdotal evidence of activity of IGF-1R antibody, ganitumab, in DSRCT patients exists21.